1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results.

MM - 762

Secondary multiple myeloma and antecedent cancer lineage

Kirti Arora

Poster Presenter: Kirti Arora

MM - 766

Isatuximab-Carfilzomib-Dexamethasone Triplet Therapy: Real-World Data Based on the Hungarian Managed Access Program

Máté Huszár

Poster Presenter: Máté Huszár

$Thumbnail for Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)$

MM - 768

Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)

Timothy Inocencio

Poster Presenter: Timothy Inocencio

$Thumbnail for Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis$

MM - 770

Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis

Roberto Mina

Poster Presenter: Roberto Mina

$Thumbnail for Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma$

MM - 780

Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Wanda Vila-Carriles

Poster Presenter: Wanda Vila-Carriles

Thumbnail for Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

MM - 785

Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

$Thumbnail for Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Waterless Empirical Taste Test (WETT) and Patient Reported Outcomes (PRO) Data From TALisman$

MM - 793

Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Waterless Empirical Taste Test (WETT) and Patient Reported Outcomes (PRO) Data From TALisman

Nolan Ngo

Poster Presenter: Nolan Ngo

$Thumbnail for Treatment-Limiting On-Target Toxicity With Talquetamab/GPRC5D-Directed Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 795

Treatment-Limiting On-Target Toxicity With Talquetamab/GPRC5D-Directed Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

Thumbnail for Correlation Between Mobilization Regimen and CD34? Stem Cell Yield in Multiple Myeloma (MM) Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT): A Single-Center Retrospective Analysis

MM - 803

Correlation Between Mobilization Regimen and CD34? Stem Cell Yield in Multiple Myeloma (MM) Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT): A Single-Center Retrospective Analysis

Solomiia Hlukhovska

Poster Presenter: Solomiia Hlukhovska